CStone Pharmaceuticals (HKG:2616)
Hong Kong
· Delayed Price · Currency is HKD 4.410
-0.190 (-4.13%)
Jun 26, 2026, 4:08 PM HKT
CStone Pharmaceuticals Employees
CStone Pharmaceuticals had 136 employees as of December 31, 2025. The number of employees increased by 1 or 0.74% compared to the previous year.
Employees
136
Change (1Y)
1
Growth (1Y)
0.74%
Revenue / Employee
2.21M HKD
Profits / Employee
-3.58M HKD
Market Cap
7.05B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,110 |
| Abbisko Cayman | 276 |
| Alphamab Oncology | 498 |
| Suzhou Ribo Life Science | 407 |
| Lepu Biopharma | 710 |
| CARsgen Therapeutics Holdings | 355 |
| Everest Medicines | 812 |
| HBM Holdings | 272 |
CStone Pharmaceuticals News
- 3 days ago - CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex for Sugemalimab across Australia and New Zealand - PRNewsWire
- 4 weeks ago - ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept - PRNewsWire
- 2 months ago - CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3) - PRNewsWire
- 3 months ago - CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0 - PRNewsWire
- 3 months ago - CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) - PRNewsWire
- 3 months ago - CStone Pharmaceuticals Earnings release: H2 2025 - Filings
- 3 months ago - CStone Pharmaceuticals Slides: H2 2025 - Filings
- 3 months ago - CStone Pharmaceuticals Annual report: H2 2025 - Filings